Assay Detail
Functional
CHEMBL4689203
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human HuH-7 cells assessed as reduction in cell viability incubated for 48 hrs by Hoechst-33342 staining based cell counting method (Rvb > 25 microM)
10
Total Activities
10
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | Huh-7 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 10 | 5.44 | 7.89 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL428647 | PACLITAXEL | 4.0 | 1 | 7.89 |
| CHEMBL53463 | DOXORUBICIN | 4.0 | 1 | 7.44 |
| CHEMBL4795706 | — | — | 1 | 5.16 |
| CHEMBL4761834 | — | — | 1 | 5.16 |
| CHEMBL4751143 | — | — | 1 | 5.16 |
| CHEMBL14762 | SELICICLIB | 2.0 | 1 | 4.85 |
| CHEMBL4793064 | — | — | 1 | 4.85 |
| CHEMBL4754002 | — | — | 1 | 4.64 |
| CHEMBL4760556 | — | — | 1 | 4.62 |
| CHEMBL4783398 | — | — | 1 | 4.60 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL428647 | PACLITAXEL | IC50 | = | 13.0 | nM | 7.89 |
| CHEMBL53463 | DOXORUBICIN | IC50 | = | 36.0 | nM | 7.44 |
| CHEMBL4795706 | — | IC50 | = | 7000.0 | nM | 5.16 |
| CHEMBL4761834 | — | IC50 | = | 7000.0 | nM | 5.16 |
| CHEMBL4751143 | — | IC50 | = | 7000.0 | nM | 5.16 |
| CHEMBL14762 | SELICICLIB | IC50 | = | 14000.0 | nM | 4.85 |
| CHEMBL4793064 | — | IC50 | = | 14000.0 | nM | 4.85 |
| CHEMBL4754002 | — | IC50 | = | 23000.0 | nM | 4.64 |
| CHEMBL4760556 | — | IC50 | = | 24000.0 | nM | 4.62 |
| CHEMBL4783398 | — | IC50 | = | 25000.0 | nM | 4.60 |